Eli Lilly’s (LLY) diabetes injection Mufenda gets approval in China

Eli Lilly and Company announced on Tuesday that the National Medical Products Administration (NMPA) in China has approved the distribution of its injection Mufenda. This injection is designed to treat diabetes, improve blood sugar control, and aid in weight loss for adults with type 2 diabetes. The approval marks a significant milestone for Eli Lilly […]